
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.040 | 4.040 | 0.000 |
Shares | 95.960 | 95.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.789 | 17.880 |
Price to Book | 3.537 | 3.321 |
Price to Sales | 2.698 | 2.209 |
Price to Cash Flow | 13.575 | 13.754 |
Dividend Yield | 2.903 | 2.916 |
5 Years Earnings Growth | 7.536 | 10.445 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 37.050 | 30.677 |
Financial Services | 19.980 | 21.764 |
Consumer Defensive | 18.630 | 12.822 |
Industrials | 9.870 | 15.686 |
Basic Materials | 7.330 | 8.216 |
Consumer Cyclical | 5.730 | 5.427 |
Technology | 1.420 | 3.446 |
Number of long holdings: 32
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.49 | 79.29 | +0.38% | |
Novartis | CH0012005267 | 12.72 | 96.18 | +0.17% | |
Roche Holding Participation | CH0012032048 | 11.69 | 261.60 | -0.19% | |
UBS Group | CH0244767585 | 4.64 | 26.78 | +1.36% | |
Holcim | CH0012214059 | 4.33 | 59.48 | +3.12% | |
Swiss Re | CH0126881561 | 4.23 | 137.35 | +0.59% | |
Richemont | CH0210483332 | 4.06 | 149.55 | +2.12% | |
Zurich Insurance Group | CH0011075394 | 3.64 | 555.20 | +0.29% | |
Alcon | CH0432492467 | 3.33 | 70.36 | +0.49% | |
ABB | CH0012221716 | 3.31 | 47.79 | +4.28% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 7.51B | -5.55 | 7.85 | - | ||
CH0429081638 | 7.51B | 0.65 | 9.70 | - | ||
CH0337393745 | 6.34B | -5.65 | 7.60 | - | ||
CSIF CH Emerging Markets Index Blue | 3.32B | -1.29 | -0.07 | 2.56 | ||
CH0017844686 | 3.32B | -1.32 | -0.16 | 2.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review